메뉴 건너뛰기




Volumn 8, Issue 5, 2001, Pages 993-996

Anti-CD20 monoclonal antibody treatment of human herpesvirus 8-associated, body cavity-based lymphoma with an unusual phenotype in a human immunodeficiency virus-negative patient

Author keywords

[No Author keywords available]

Indexed keywords

RITUXIMAB;

EID: 0034828773     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.8.5.993-996.2001     Document Type: Article
Times cited : (40)

References (38)
  • 12
    • 0002049404 scopus 로고    scopus 로고
    • Rituximab/CHOP chemoimmunotherapy in patients with low-grade lymphoma: Progression-free survival after 3 years' median follow-up
    • (1999) Blood , vol.94 , Issue.SUPPL. 1
    • Czuzman, M.1    Grino-López, A.J.2    White, C.3
  • 22
    • 0018341716 scopus 로고
    • Superiority of adriamycin-containing combination chemotherapy in the treatment of diffuse lymphoma: A Southwest Oncology Group study
    • (1979) Cancer , vol.43 , pp. 417-425
    • Jones, S.E.1
  • 24
  • 27
    • 0031761148 scopus 로고    scopus 로고
    • Newer treatments for non-Hodgkin's lymphoma: Monoclonal antibodies
    • (1998) Oncology , vol.12 , Issue.SUPPL. 8 , pp. 63-76
    • Maloney, D.1    Press, O.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.